Basic Information
RNALocate ID: | RLID:11003024 |
RNA Symbol: | hsa-miR-512-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-512-3p |
RNA ID: | miRBase:MIMAT0002823 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23382797 |
Tissue/Cell Line: | Brain tissue |
Method: | Microarray |
Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID-D:11000489 | Microvesicle | Fibroblasts | |
RLID-D:11001252 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-512-3p | Oral squamous cell carcinoma | MNDR-E-MI-56559 |
MNDR | hsa-miR-512-3p | Non-hodgkin lymphoma | MNDR-E-MI-56560 |
MNDR | hsa-miR-512-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-56561 |
MNDR | hsa-miR-512-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-56562 |
MNDR | hsa-miR-512-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-56563 |
MNDR | hsa-miR-512-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-56564 |
MNDR | hsa-miR-512-3p | Her2-receptor positive breast cancer | MNDR-E-MI-56565 |
MNDR | hsa-miR-512-3p | Dermatomyositis | MNDR-E-MI-56566 |
MNDR | hsa-miR-512-3p | Prostate cancer | MNDR-E-MI-56567 |
MNDR | hsa-miR-512-3p | Gastric cancer | MNDR-E-MI-56568 |
MNDR | hsa-miR-512-3p | Lung cancer | MNDR-E-MI-56569 |
MNDR | hsa-miR-512-3p | Parkinson disease | MNDR-E-MI-56570 |
MNDR | hsa-miR-512-3p | Breast cancer | MNDR-E-MI-56571 |
MNDR | hsa-miR-512-3p | Pancreatic cancer | MNDR-E-MI-56572 |
MNDR | hsa-miR-512-3p | Melanoma | MNDR-E-MI-56573 |
MNDR | hsa-miR-512-3p | Nephroblastoma | MNDR-E-MI-56574 |
MNDR | hsa-miR-512-3p | Colon cancer | MNDR-E-MI-56575 |
MNDR | hsa-miR-512-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-56576 |
MNDR | hsa-miR-512-3p | Familial ovarian cancer | MNDR-E-MI-56577 |
MNDR | hsa-miR-512-3p | Malignant glioma | MNDR-E-MI-56578 |
MNDR | hsa-miR-512-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-56579 |
MNDR | hsa-miR-512-3p | Liposarcoma | MNDR-E-MI-56580 |
MNDR | hsa-miR-512-3p | Inclusion body myositis | MNDR-E-MI-56581 |
MNDR | hsa-miR-512-3p | Middle cerebral artery infarction | MNDR-E-MI-56582 |
MNDR | hsa-miR-512-3p | Carcinoma lung non-small-cell | MNDR-E-MI-56583 |
MNDR | hsa-miR-512-3p | Lung adenocarcinoma | MNDR-E-MI-56584 |
MNDR | hsa-miR-512-3p | Bladder urothelial carcinoma | MNDR-E-MI-56585 |
MNDR | hsa-miR-512-3p | Pancreatic adenocarcinoma | MNDR-E-MI-56586 |
MNDR | hsa-miR-512-3p | Cholangiocarcinoma | MNDR-E-MI-56587 |
MNDR | hsa-miR-512-3p | Esophageal cancer | MNDR-E-MI-56588 |
MNDR | hsa-miR-512-3p | Hepatocellular carcinoma | MNDR-E-MI-56589 |
MNDR | hsa-miR-512-3p | Embryonal cancer | MNDR-E-MI-56590 |
MNDR | hsa-miR-512-3p | Familiar ovarian carcinoma | MNDR-E-MI-56591 |
MNDR | hsa-miR-512-3p | B-cell non-hodgkin lymphoma | MNDR-E-MI-56592 |
MNDR | hsa-miR-512-3p | Malignant pleural mesothelioma | MNDR-E-MI-56593 |
MNDR | hsa-miR-512-3p | Hodgkin disease | MNDR-E-MI-56594 |
MNDR | hsa-miR-512-3p | Tonsil cancer | MNDR-E-MI-56595 |
MNDR | hsa-miR-512-3p | Colorectal cancer | MNDR-E-MI-56596 |
MNDR | hsa-miR-512-3p | Nasopharynx carcinoma | MNDR-E-MI-56597 |
MNDR | hsa-miR-512-3p | Multiple myeloma | MNDR-E-MI-56598 |
MNDR | hsa-miR-512-3p | Nasopharyngeal cancer | MNDR-E-MI-56599 |
MNDR | hsa-miR-512-3p | Chronic pain | MNDR-E-MI-56600 |
MNDR | hsa-miR-512-3p | Breast cancer her3+ negative | MNDR-E-MI-56601 |
MNDR | hsa-miR-512-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-56602 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CD44 | Homo sapiens | RR00301717 |
TOP